NTV: Stanbic extends UGX 133B credit to QCIL to boost drug production

Released On May 23, 2025

Emmanuel Katongole, Executive Chairman of QCIL, emphasized that the investment will enhance the company's ability to supply essential medicines across Africa.

Stanbic extends UGX 133B credit to QCIL to boost drug production

Latest Media Releases

1

Business Focus Magazine: Qcil Beyond Healing

1 September 2025

DEFINED BY ITS HOLISTIC APPROACH TO WELLNESS, AFRICAN PHARMACEUTICAL MANUFACTURER QCIL IS ENABLING MORE FULFILLING LIVES ACROSS THE CONTINENT.

Read more
lab qc

CEO Magazine: How Qcil is Rewriting Africa's Healthcare Story from Dependency to Self-Reliance

27 August 2025

CEO Magazine: How Qcil is Rewriting Africa's Healthcare Story from Dependency to Self-Reliance

Read more
img 1464

CEO Magazine: Qcil's Profits jumps 22% to Shs.40.7 billion on steady sales and smart pricing

18 July 2025

CEO Magazine: Qcil's Profits jumps 22% to Shs.40.7 billion on steady sales and smart pricing

Read more
img 1436

Qcil POSTS RECORD PROFITS AND ANNOUNCES AMBITIOUS EXPANSION

17 July 2025

“This expansion will enable us to do more for our patients, our people, and our economy.” said Mr. Katongole.

Read more
imgl1364

Qcil Honours STEM Students from Uganda and Namibia

7 July 2025

Quality Chemical Industries Limited (Qcil) held a certificate award ceremony to celebrate 45 Science, Technology, Engineering and Mathematics (STEM) interns, including 8 from Namibia, who successfully completed their internship program.

Read more